Rankings
▼
Calendar
ALKS Q2 2023 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$617M
+123.5% YoY
Gross Profit
$554M
89.8% margin
Operating Income
$281M
45.6% margin
Net Income
$237M
38.4% margin
EPS (Diluted)
$1.38
QoQ Revenue Growth
+114.7%
Cash Flow
Operating Cash Flow
$216M
Free Cash Flow
$206M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$2.2B
Total Liabilities
$907M
Stockholders' Equity
$1.3B
Cash & Equivalents
$666M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$617M
$276M
+123.5%
Gross Profit
$554M
$218M
+154.4%
Operating Income
$281M
-$34M
+916.3%
Net Income
$237M
-$30M
+886.7%
Revenue Segments
Manufacturing Revenue
$32M
100%
← FY 2023
All Quarters
Q3 2023 →